Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390.
Monika A NiewczasAndrzej S KrolewskiPublished in: Diabetes care (2018)